A detailed history of Mirae Asset Global Etfs Holdings Ltd. transactions in Savara Inc stock. As of the latest transaction made, Mirae Asset Global Etfs Holdings Ltd. holds 69,788 shares of SVRA stock, worth $218,436. This represents 0.0% of its overall portfolio holdings.

Number of Shares
69,788
Previous 50,663 37.75%
Holding current value
$218,436
Previous $204,000 44.61%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$3.96 - $5.07 $75,735 - $96,963
19,125 Added 37.75%
69,788 $295,000
Q2 2024

Aug 14, 2024

BUY
$3.66 - $5.34 $185,426 - $270,540
50,663 New
50,663 $204,000

Others Institutions Holding SVRA

About Savara Inc


  • Ticker SVRA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 114,043,000
  • Market Cap $357M
  • Description
  • Savara Inc., a clinical stage biopharmaceutical company, focuses on rare respiratory diseases. Its lead product candidate is molgramostim, an inhaled granulocyte-macrophage colony-stimulating factor, which is in Phase III development stage for the treatment of autoimmune pulmonary alveolar proteinosis. The company is headquartered in Austin, Texas.
More about SVRA
Track This Portfolio

Track Mirae Asset Global Etfs Holdings Ltd. Portfolio

Follow Mirae Asset Global Etfs Holdings Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mirae Asset Global Etfs Holdings Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Mirae Asset Global Etfs Holdings Ltd. with notifications on news.